Clinical

CMAX has extensive experience in conducting clinical studies in healthy volunteers and specific patient groups. These studies are conducted in a world class 48 bed facility for both local and international regulatory submissions. All studies are conducted in compliance with the principles of ICH GCP and local regulatory requirements and are internally audited.

We provide a high level of responsiveness and flexibility and are committed to timely provision of quality data. Access to specialist consultants ( pharmacokinetic and medical) further enhances our expertise to meet client needs Independent Quality Assurance reviews are performed to ensure GCP compliance.

CMAX has expertise in the following therapeutic areas:

• Allergy
• Alzheimers
• Anaesthesia
• Arthritis
• Asthma
• Bioequivalence
• Cardiovascular
• Dengue Fever
• Dermatology
• Diabetes
• Drug Interaction Studies
• First Time in Man Studies/li>
• Food Effect Studies
• Hepatitis C
• Hormone Replacement Therapy
• Influenza
• Japanese Encephalitis
• Malaria
• Osteoarthritis
• Oncology (Phase I)
• Pain (analgesia)
• Parkinsons Disease
• Psoriasis
• Renal Disease
• Rheumatoid Arthritis
• Vaccine Studies